Tilray is a global leader in cannabis research, cultivation, processing and distribution. We aspire to lead, legitimize and define the future of our industry by building the world’s most trusted cannabis and hemp company. A proud pioneer, we are the first GMP-certified medical cannabis producer to supply cannabis flower and extract products to tens of thousands of patients, physicians, pharmacies, hospitals, governments and researchers on five continents. sativas, hybrids, and CBD-rich varieties. Medical cannabis is available in two primary forms: extracts and dried flower. Each can be administered or consumed via a variety of methods. We take a scientific approach to product development. Our product line focuses on active ingredients and standardized, well-defined preparations. We use formulations and delivery formats that are intended to allow for consistent and measured dosing, and we test all of our products for potency and purity. Each of our commercial products are developed with comprehensive analysis and thorough documentation, including stability profiles, certificates of analysis, monographs and drug master files. For the therapeutic value and risks of cannabinoid-based medicines to be fully understood, Tilray believes it is critical to evolve current scientific understanding of the field. Our clinical research program is designed with that in mind. Participation in clinical trials is a differentiating element of our research and development program. We have developed techniques that achieve clinical grade isolates in order to facilitate participation in clinical trials conducted by select research partners at world-leading hospitals and universities.